Aphios Corporation
PrivateLast Round
Grant
Dec 11, 2024
Est. Valuation
$70.09M
Total Funding Raised
$4.06M
Company Overview
Aphios Corporation is a biopharmaceutical company that develops enhanced therapeutics for health maintenance and the treatment of human diseases with a focus on infectious diseases, cancer, and central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aphios Corporation Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Aphios Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2024 | ||||
| Grant | Sep 20, 2024 | ||||
| Grant | Sep 6, 2023 | ||||
| Grant | Mar 3, 2023 | ||||
| Crowdfunding | Jul 31, 2022 | ||||
Crowdfunding | Dec 31, 2019 |
Aphios Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| National Center for Complementary and Integrative Health | Grant |
| National Institute on Aging | Grant |
| Netcapital | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2024
$505K grant round led by National Institute on Aging.
- Sep 20, 2024
$416K grant from National Center for Complementary and Integrative Health.
Aphios Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aphios Corporation's valuation, stock price, and market status.